Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2009
03/11/2009CN101384558A Gaba-b receptor modulators
03/11/2009CN101381364A Starburst molecule containing 2,4,6-tri(2-thineyl)-1,3,5-s-triazine unit and preparation method thereof and use
03/11/2009CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
03/11/2009CN100467464C Long-chain aromatic piperazine modified duloxetine-like compound, and its preparation and use
03/10/2009US7501529 7-Ethynyl-2,4,9-trithiaadamantane and related methods
03/10/2009US7501514 reacting said mixture of cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane with an achiral acid (e.g.HCl, HBr, H2SO4, HBF4, methanesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, citric acid, maleic or formic acid), resulting conglomerate salt, resolving the mixture by crystallization
03/10/2009US7501447 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
03/10/2009US7501446 3-(Pyrid-3-yl)-5-(thiophen-2-yl)-pyrazoles; prenyl-protein transferase inhibitors
03/10/2009US7501444 3-Pyrid-3-yl- pyrazoles in which pyrazole ring is additionally substituted with a halogenated phenyl group; prenyl-protein transferase inhibitors
03/10/2009US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/10/2009US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens
03/10/2009CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
03/10/2009CA2347773C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
03/10/2009CA2345069C 2-phenylpyran-4-one derivatives
03/10/2009CA2342210C Thiazoline acid derivatives
03/05/2009WO2009029439A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009028495A1 Agent for fungal dermatitis
03/05/2009WO2009026837A1 Derivatives of 4,5-disubstituted phenyl-3h-1,2-dithiole-3-thione, -one, -ketoxime and their use
03/05/2009WO2009010477A8 Piperidine-4-acetic acid derivatives and their use
03/05/2009WO2009007747A3 Hydantoin derivatives used as mmp12 inhibitors
03/05/2009WO2008151828A3 Novel microbiocides
03/05/2009WO2008147812A3 4' substituted compounds having 5-ht6 receptor affinity
03/05/2009WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062361 Therapeutic hydantoins
03/05/2009US20090062358 Peroxisome proliferator activated receptor alpha agonists
03/05/2009US20090062348 Antifungal Agent Containing Pyridine Derivative
03/05/2009US20090062344 Therapeutic substituted piperidone compounds
03/05/2009US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS
03/05/2009US20090060874 Bicyclic pyrrolidine derivatives
03/05/2009US20090058289 Materials for Organic Electroluminescent Devices
03/05/2009US20090057620 Polymer-nanoparticle compositions and methods of making and using same
03/05/2009CA2697663A1 Substituted pyrazole derivative
03/05/2009CA2694911A1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/04/2009EP2030981A1 Compounds for proteasome enzyme inhibition
03/04/2009EP2030635A1 Composition for diagnosing amyloid-related disease
03/04/2009EP2029582A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof
03/04/2009EP2029576A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/04/2009EP2029575A1 Substituted spirocyclic cgrp receptor antagonists
03/04/2009EP2029572A2 Organic compounds
03/04/2009EP2029558A2 Compounds and methods for modulating fxr
03/04/2009EP2029543A2 Substituted 3-cyanopyridines as protein kinase inhibitors
03/04/2009EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase
03/04/2009EP1380306B1 Remedies for restless leg syndrome
03/04/2009EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity
03/04/2009EP0869974B1 Compounds with growth hormone releasing properties
03/04/2009CN101379140A Photosensitizer dye
03/04/2009CN101379034A Benzamide and heteroarene derivatives as CETP inhibitors
03/04/2009CN101379028A Chemical compounds
03/04/2009CN101378756A Piperidine derivatives as CXCR3 receptor antagonists
03/04/2009CN100465173C A selective kinase inhibitor
03/04/2009CN100465163C Cis-2,4,5-triaryl-imidazolines
03/03/2009US7498441 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment
03/03/2009US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine
03/03/2009US7498405 Halogen-substituted thienyl compounds
03/03/2009US7498358 Human ADAM-10 inhibitors
03/03/2009US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria
03/03/2009US7498343 Mycobacterial inhibitors
03/03/2009US7498328 Derivatives of sulphonamides, their preparation and use as medicaments
02/2009
02/26/2009WO2009026408A1 Therapeutic quinoline and naphthalene derivatives
02/26/2009WO2009026407A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
02/26/2009WO2009026204A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
02/26/2009WO2009024615A1 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
02/26/2009WO2009024342A2 Novel microbiocides
02/26/2009WO2009024341A2 Condensed anthran i lami de derivatives as insectisides
02/26/2009WO2009024287A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
02/26/2009WO2007014226A3 Compounds for the treatment of neurodegeneration and stroke
02/26/2009US20090054514 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias
02/26/2009US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
02/26/2009US20090054492 such as 3-iodo-N-{2-[1-methyl-4-(trifluoromethyl)-1H-pyrazol-3-yl]ethyl}thiophene-2-carboxamide for use as fungicide, for treating plants; for phytopathogenic fungi of crops
02/26/2009US20090054464 Hdac inhibitor
02/26/2009US20090054462 Hydroisoindoline tachykinin receptor antagonists
02/26/2009US20090054460 Piperazine derivatives and methods of use
02/26/2009US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors
02/26/2009US20090054440 Quinoline derivatives as neurokinin receptor antagonists
02/26/2009US20090054429 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
02/26/2009US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands
02/26/2009US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound
02/26/2009US20090054396 Substituted thiophenes and uses thereof
02/26/2009CA2697284A1 Therapeutic quinoline and naphthalene derivatives
02/26/2009CA2697254A1 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
02/26/2009CA2696693A1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
02/26/2009CA2696429A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
02/25/2009EP2027117A2 Process for preparing 7-(acryloyl)-indoles
02/25/2009EP2027116A2 Thiophene-carboxamides useful as inhibitors of protein kinases
02/25/2009EP2027107A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
02/25/2009EP2027096A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
02/25/2009EP2027088A2 Compounds for the treatment of spinal muscular atrophy and other uses
02/25/2009EP1904476B1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
02/25/2009EP1578726B1 Tetrahydroquinoline derivatives
02/25/2009EP1506188B1 Process for the preparation of a hydrate of an anthranilic acid derivative
02/25/2009EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors
02/25/2009CN101374820A Piperazine compounds with a herbicidal action
02/25/2009CN101374811A Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations